Steroid-Spiked Supplement Bill Lingers In Roiling Senate Climate
This article was originally published in The Tan Sheet
Executive Summary
Time for passing the legislation is running short with Congress leaving to focus on campaigns and with multiple issues already claiming priority for congressional action. The mid-term elections also could diminish the bill’s chances, as well as change control of the Senate and create large turnover in the House.
You may also be interested in...
Hatch Proposes Tougher Penalties For Steroid-Spiked Supplements
Industry trade groups back the Designer Anabolic Steroid Control Act of 2012, which would create stiffer penalties for firms that taint supplements with anabolic steroids and strengthen DEA’s ability to identify and remove products with steroid analogues.
US Health And Wellness People News: CHPA, Bayer, Viatris, Qnovia, Powerade
Sanofi consumer health scientific affairs lead moves to CHPA; change in Bayer’s US consumer health marketing helm; Viatris CCO moves from same post at Moderna; Qnovia expands scientific advisory board; and Powerade powers Girls Inc. scholarships, programs.
Australian Teeth Whitener Marketer Frowns On Industry Self-Regulation Referencing US Laws
HiSmile appeals NAD recommendation following review on P&G challenge to discontinue ad claims on its website and in social media videos stating peroxide-containing whitening products are “painful” or cause pain, break down and impact gums and teeth, or “damage” gums.